Seed Therapeutics Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Series A3

  • Latest Deal Amount
  • $30M

  • Investors
  • 3

Seed Therapeutics General Information

Description

Operator of a biotechnology company intended to develop targeted protein degradation therapeutics for diseases with limited treatment options. The company specializes in research and development and is engaged in harnessing and engineering molecules that use molecular glues to attack protein targets, enabling the oncology and neurodegeneration sectors to tackle previously undruggable diseases with novel drug candidates.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 411 Swedeland Road
  • Suite 1000
  • King of Prussia, PA 19406
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 411 Swedeland Road
  • Suite 1000
  • King of Prussia, PA 19406
  • United States

Seed Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Seed Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A3) 01-Aug-2025 $30M Completed Clinical Trials - General
4. Secondary Transaction - Private 28-Jan-2025 Completed Clinical Trials - General
3. Accelerator/Incubator 10-Oct-2024 Completed Clinical Trials - General
2. Early Stage VC (Series A1) $20M Completed Clinical Trials - General
1. Corporate 12-Nov-2020 $20M $20M Completed Clinical Trials - General
To view Seed Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Seed Therapeutics Patents

Seed Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026101959-A1 Heteroaromatic indolesulfonamides Pending 06-Nov-2024
WO-2025189015-A1 Heteroaromatic indolesulfonamides Pending 07-Mar-2024
WO-2025189015-A8 Heteroaromatic indolesulfonamides Pending 07-Mar-2024
AU-2024265472-A1 Heteroaromatic indolesulfonamides Pending 01-May-2023
EP-4704836-A1 Heteroaromatic indolesulfonamides Pending 01-May-2023 C07D417/12
To view Seed Therapeutics’s complete patent history, request access »

Seed Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Seed Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eisai Corporate Venture Capital Minority
Endless Frontier Labs Accelerator/Incubator
Lilly USA Corporation Minority
To view Seed Therapeutics’s complete investors history, request access »

Seed Therapeutics FAQs

  • When was Seed Therapeutics founded?

    Seed Therapeutics was founded in 2019.

  • Where is Seed Therapeutics headquartered?

    Seed Therapeutics is headquartered in King of Prussia, PA.

  • What is the size of Seed Therapeutics?

    Seed Therapeutics has 27 total employees.

  • What industry is Seed Therapeutics in?

    Seed Therapeutics’s primary industry is Drug Discovery.

  • Is Seed Therapeutics a private or public company?

    Seed Therapeutics is a Private company.

  • What is the current valuation of Seed Therapeutics?

    The current valuation of Seed Therapeutics is .

  • What is Seed Therapeutics’s current revenue?

    The current revenue for Seed Therapeutics is .

  • How much funding has Seed Therapeutics raised over time?

    Seed Therapeutics has raised $50M.

  • Who are Seed Therapeutics’s investors?

    Eisai, Endless Frontier Labs, and Lilly USA have invested in Seed Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process